Current Report Filing (8-k)
February 21 2023 - 04:17PM
Edgar (US Regulatory)
0000032604 false CHX 0000032604
2023-02-17 2023-02-17 0000032604 us-gaap:CommonStockMember
exch:XNYS 2023-02-17 2023-02-17 0000032604
us-gaap:CommonStockMember exch:XCHI 2023-02-17 2023-02-17
0000032604 emr:A0.375NotesDue2024Member 2023-02-17 2023-02-17
0000032604 emr:A1.250NotesDue2025Member 2023-02-17 2023-02-17
0000032604 emr:A2.000NotesDue2029Member 2023-02-17 2023-02-17
iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 17, 2023
Emerson Electric Co.
(Exact name of registrant as specified in its charter)
Missouri |
1-278 |
43-0259330 |
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
8000 West Florissant Avenue,
St. Louis,
Missouri
63136 |
(Address
of principal executive offices and zip code) |
Registrant’s telephone number, including area code: (314)
553-2000
Not Applicable
(Former name or former address, if changed since last
report.)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
Title of each class |
|
Trading Symbols |
|
Name of each exchange on which registered |
Common Stock, $0.50 par value per share |
|
EMR |
|
New York Stock Exchange |
Common Stock, $0.50 par
value per share |
|
EMR |
|
NYSE Chicago |
0.375% Notes due 2024 |
|
EMR 24 |
|
New York Stock Exchange |
1.250% Notes due 2025 |
|
EMR 25A |
|
New York Stock Exchange |
2.000% Notes due 2029 |
|
EMR 29 |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ¨
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ¨
|
Item 1.01. |
Entry into a Material Definitive Agreement. |
The information provided in Item 2.03 of this Current Report on
Form 8-K is hereby incorporated into this Item 1.01 by
reference.
|
Item 1.02. |
Termination of a Material Definitive Agreement. |
The information provided in Item 2.03 of this Current Report on
Form 8-K is hereby incorporated into this Item 1.02 by
reference
|
Item 2.03. |
Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant. |
On February 17, 2023, the Company entered into a $3.5 billion
five-year revolving credit facility (the “2023 Facility”) with
JPMorgan Chase Bank, N.A., as agent, Citibank, N.A., as syndication
agent, and the lenders named therein. The 2023 Facility expires in
February, 2028 and replaces a similar $3.5 billion five-year
revolving credit facility dated May 23, 2018 among the
Company, JPMorgan Chase Bank, N.A., as agent, and the lenders party
thereto, which was terminated on February 17, 2023. There are
no outstanding loans or letters of credit under the 2023 Facility.
The Company has not incurred any borrowings under this or prior
similar facilities, and has no current intention to do so. The 2023
Facility supports general corporate purposes, including commercial
paper borrowings.
The 2023 Facility is unsecured and may be accessed under various
interest rate alternatives, at the Company’s option. The Company
may from time to time designate any of its eligible subsidiaries as
subsidiary borrowers under the 2023 Facility. The Company has
unconditionally and irrevocably guaranteed the obligations of each
of its subsidiaries in the event a subsidiary is named a borrower
under the 2023 Facility. Loans and letters of credit may be
denominated in U.S. dollars or certain other currencies. The
Company must pay facility fees on the aggregate amounts available
under the 2023 Facility, as specified in the credit agreement. The
2023 Facility contains customary representations, warranties,
covenants and events of default.
In the ordinary course of their respective businesses, the lenders
and their respective affiliates engage in, and may in the future
engage in, commercial banking and/or investment banking
transactions and/or advisory services with the Company and its
affiliates.
The foregoing summary of the 2023 Facility is not complete and is
qualified in its entirety by reference to the actual credit
agreement, which is attached as Exhibit 10.1 hereto and is
incorporated herein by reference.
|
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
|
Date:
February 21, 2023 |
EMERSON
ELECTRIC CO. |
|
|
|
|
By: |
/s/
John A. Sperino |
|
|
John
A. Sperino |
|
|
Vice President and Assistant Secretary
|
Emerson Electric (NYSE:EMR)
Historical Stock Chart
From Aug 2023 to Sep 2023
Emerson Electric (NYSE:EMR)
Historical Stock Chart
From Sep 2022 to Sep 2023